CHRU Lille - Hopital Roger Salengro — Clinical Trial Site

9 Registered trials

4 Currently recruiting

Organisation

CHRU Lille - Hopital Roger Salengro

Location

Lille Cedex, France

Identifier

ORG-100029833

Address

Avenue Du Professeur Emile Laine, 59037, France

Departments

#40526: Service de Neurologie et Pathologie du Mouvement, Centre Expert Parkinson
Department of Neurology
Gynécologie obstétrique
Intensive Care Unit
Neurologie
Neurophysiology
Réanimation
Service de neurologie et pathologie neurovasculaire

Clinical trials at this site (9)

Search interface

A Study to Assess if BIIB080 Can Change Clinical Dementia Rating-Sum of Boxes Scores, and BIIB080 Safety and Tolerability When Injected Into… Not authorised

2022-501644-15-00 Mild Cognitive Impairment due to Alzheimer's Disease Al 4
Efficacy of early intravenous high-dose vitamin C in post-cardiac arrest shock: a multicenter, randomized controled to standard treatment, o… Recruiting

2022-500717-64-00 cardiac arrest 4 2023-12-27
Aspirin for the Prevention of Preeclampsia and Pregnancy outcomes in nulliparous women after Assisted Reproductive Technology. Recruiting

2022-500933-10-00 Preeclampsia during pregnancy 11 2023-08-02
Tranexamic acid for hyperacute spontaneous IntraCerebral Haemorrhage (TICH-3) Recruiting

2022-500587-35-01 Stroke 5 2023-07-06
A RANDOMIZED DOUBLE BLIND, PLACEBO-CONTROLLED NATIONAL MULTICENTER PHASE 3 TRIAL TO EVALUATE THE EFFICACY OF AZATHIOPRINE FOR THE PREVENTION… Recruiting

2022-500520-30-00 neurology 5 2023-03-01
A Study to Learn About the Safety of BIIB080 and Whether it Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzhe… Ended

2022-501644-15-01 Mild Cognitive Impairment due to Alzheimer's Disease Al 4 2023-09-28
An extension of the orchestra (PD0053) study to learn how safe minzasolmin is and if it works long-term in participants with Parkinson’s dis… Ended

2022-500424-30-00 Parkinson’s disease 4 2022-12-28
European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial (SolidAct) Ended

2022-500385-99-00 SARS-CoV II infection (Coronavirus disease) 5 2021-06-03
EQU-001 as an Add-On Drug for People with Focal Seizures while on Medication Ended

2022-500302-18-00 Epilepsy 4